Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Jazz Pharmaceuticals
Related studies linked through entity extraction aliases.
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
- Status
- RECRUITING
- Phase
- PHASE2
Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
- Status
- COMPLETED
- Phase
- PHASE2
CPX-351 Real-World Effectiveness and Safety Study
- Status
- COMPLETED
- Phase
- N/A
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)
- Status
- COMPLETED
- Phase
- PHASE2
Lurbinectedin + Doxorubicin In Leiomyosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Delphi Consensus Excessive Daytime Sleepiness in OSA
- Status
- COMPLETED
- Phase
- N/A
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
- Status
- RECRUITING
- Phase
- PHASE1
Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Status
- RECRUITING
- Phase
- PHASE2
Phase IB/II of CPX-351 for Relapse Prevention in AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE3
Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A